Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm

International Journal of Cancer

Volumn 132, Issue 7, 2013, Pages 1565-1571

  Rietbergen, Michelle M ^a   Leemans, C René ^a   Bloemena, Elisabeth ^a   Heideman, Daniëlle A M ^a   Braakhuis, Boudewijn J M ^a   Hesselink, Albertus T ^a   Witte, Birgit I ^a   De Jong, Robert J Baatenburg ^b   Meijer, Chris J L M ^a   Snijders, Peter J F ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

HPV; oropharyngeal cancer; p16; squamous cell carcinoma

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; FORMALDEHYDE; PARAFFIN; VIRUS DNA;

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DNA DETERMINATION; EMBEDDING; FEMALE; FROZEN SECTION; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; OROPHARYNX CARCINOMA; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TISSUE FIXATION; VALIDATION STUDY; VIRUS DETECTION; WART VIRUS;

ALGORITHMS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NETHERLANDS; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; PREVALENCE; PROGNOSIS; TUMOR VIRUS INFECTIONS; VIRAL LOAD;

EID: 84873078950     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27821     Document Type: Article

References (37)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127: 2893-917.
2. Leemans CR, Braakhuis BJ, Brakenhoff RH,. The molecular biology of head and neck cancer. Nat Rev Cancer 2011; 11: 9-22.
3. Marur S, D'Souza G, Westra WH, et al. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010; 11: 781-9.
4. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-56.
5. D'Souza G, Zhang HH, D'Souza WD, et al. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol 2010; 46: 100-4.
6. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008; 100: 407-20.
7. Heck JE, Berthiller J, Vaccarella S, et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010; 39: 166-81.
8. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
9. Fakhry C, Gillison ML,. Clinical implications of human papillomavirus in head and neck cancers. J Clin Oncol 2006; 24: 2606-11.
10. Hafkamp HC, Manni JJ, Speel EJ,. Role of human papillomavirus in the development of head and neck squamous cell carcinomas. Acta Otolaryngol 2004; 124: 520-6.
11. Shaw R, Robinson M,. The increasing clinical relevance of human papillomavirus type 16 (HPV-16) infection in oropharyngeal cancer. Br J Oral Maxillofac Surg 2011; 49: 423-9.
12. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011; 29: 4294-301.
13. Braakhuis BJ, Snijders PJ, Keune WJ, et al. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J Natl Cancer Inst 2004; 96: 998-1006.
14. Fischer CA, Zlobec I, Green E, et al. Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality? Int J Cancer 2010; 126: 1256-62.
15. Klussmann JP, Preuss SF, Speel EJ,. [Human papillomavirus and cancer of the oropharynx. Molecular interaction and clinical implications]. HNO 2009; 57: 113-22.
16. Charfi L, Jouffroy T, de Cremoux P, et al. Two types of squamous cell carcinoma of the palatine tonsil characterized by distinct etiology, molecular features and outcome. Cancer Lett 2008; 260: 72-8.
17. de Camargo CM, de Souza DL, Curado MP,. International incidence of oropharyngeal cancer: A population-based study. Oral Oncol 2012; 48: 484-90.
18. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-72.
19. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008; 26: 612-9.
20. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009; 125: 362-6.
21. Schache AG, Liloglou T, Risk JM, et al. Evaluation of human papilloma virus diagnostic testing in oropharyngeal squamous cell carcinoma: sensitivity, specificity, and prognostic discrimination. Clin Cancer Res 2011; 17: 6262-71.
22. Rampias T, Sasaki C, Weinberger P, et al. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009; 101: 412-23.
23. Reuschenbach M, Waterboer T, Wallin KL, et al. Characterization of humoral immune responses against p16, p53, HPV16 E6 and HPV16 E7 in patients with HPV-associated cancers. Int J Cancer 2008; 123: 2626-31.
24. Snijders PJ, van den Brule AJ, Meijer CJ,. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. J Pathol 2003; 201: 1-6.
25. El-Naggar AK, Westra WH,. p16 expression as a surrogate marker for HPV-related oropharyngeal carcinoma: a guide for interpretative relevance and consistency. Head Neck 2012; 34: 459-61.
26. Harris SL, Thorne LB, Seaman WT, et al. Association of p16(INK4a) overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue. Head Neck 2011; 33: 1622-7.
27. van den Brule AJ, Pol R, Fransen-Daalmeijer N, et al. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40: 779-87.
28. Schmitt M, Bravo IG, Snijders PJ, et al. Bead-based multiplex genotyping of human papillomaviruses. J Clin Microbiol 2006; 44: 504-12.
29. de Roda Husman AM, Snijders PJ, Stel HV, et al. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995; 72: 412-7.
30. Loseke S, Grage-Griebenow E, Wagner A, et al. Differential expression of IFN-alpha subtypes in human PBMC: evaluation of novel real-time PCR assays. J Immunol Methods 2003; 276: 207-22.
31. Gerlinger M, Rowan AJ, Horswell S, et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 2012; 366: 883-92.
32. Lundberg M, Leivo I, Saarilahti K, et al. Increased incidence of oropharyngeal cancer and p16 expression. Acta Otolaryngol 2011; 131: 1008-11.
33. Braakhuis BJ, Visser O, Leemans CR,. Oral and oropharyngeal cancer in The Netherlands between 1989 and 2006: Increasing incidence, but not in young adults. Oral Oncol 2009; 45: e85-e89.
34. D'Souza G, Dempsey A,. The role of HPV in head and neck cancer and review of the HPV vaccine. Prev Med 2011; 53 (Suppl 1): S5-S11.
35. Pierce JP, Messer K, White MM, et al. Prevalence of heavy smoking in California and the United States, 1965-2007. JAMA 2011; 305: 1106-12.
36. Agius PA, Pitts MK, Smith AM, et al. Sexual behaviour and related knowledge among a representative sample of secondary school students between 1997 and 2008. Aust NZ J Public Health 2010; 34: 476-81.
37. Bajos N, Bozon M, Beltzer N, et al. Changes in sexual behaviours: from secular trends to public health policies. AIDS 2010; 24: 1185-91.